A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer
一项针对STK11缺陷型非小细胞肺癌的mTORC1/2抑制剂II期临床试验
期刊:npj Precision Oncology
影响因子:6.8
doi:10.1038/s41698-025-00838-4
Gary Middleton # ,Helen L Robbins # ,Peter Fletcher ,Joshua Savage ,Manita Mehmi ,Yvonne Summers ,Alastair Greystoke ,Nicola Steele ,Sanjay Popat ,Pooja Jain ,James Spicer ,Judith Cave ,Paul Shaw ,David Gilligan ,Danielle Power ,Dean Fennell ,Maya Bajracharya ,David J McBride ,Uma Maheswari ,Alexander M Frankell ,Charles Swanton ,Andrew D Beggs ,Lucinda Billingham
ORC1
细胞生物学
肿瘤
肿瘤免疫
肺癌
STK11
mTOR